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ABSTRACT  The  heart's  physiological  performance,  unlike  that  of  skeletal 
muscle, is regulated primarily by variations in the contractile force developed 
by the individual myocardial fibers.  In an attempt to identify the basis for the 
characteristic properties of myocardial contraction, the individual cardiac con- 
tractile  proteins  and  their  behavior in contractile  models in vitro have been 
examined.  The low shortening velocity of heart muscle appears to reflect the 
weak ATPase activity of cardiac myosin, but this enzymatic activity probably 
does not determine active state intensity.  Quantification  of the effects of Ca  ++ 
upon cardiac actomyosin supports the view that myocardial contractility can 
be modified by changes in the amount of calcium released during excitation- 
contraction coupling. Exchange of intracellular K + with Na  + derived from the 
extracellular  space  also  could  enhance  myocardial  contractility  directly,  as 
highly  purified cardiac  actomyosin is stimulated when K + is replaced  by an 
equimolar amount  of Na  +.  On  the other hand,  cardiac  glycosides and  cate- 
cholamines, agents which greatly increase the contractility of the intact heart, 
were found to be without significant actions upon highly purified reconstituted 
cardiac actomyosin. 
Regulation of contraction in mammalian  cardiac and skeletal muscle, which 
have many common biochemical and morphological features,  is achieved by 
different  physiological  mechanisms.  Rapid  trains  of stimuli  delivered  to  a 
skeletal muscle fiber through its motor nerve enhance tension development by 
causing  the  summation  of  individual  contractile  responses  or,  in  its  fully 
developed form,  a  powerful  tetanic  contraction.  In  the  heart,  on  the  other 
hand,  fusion  of contractile  responses does not  occur  because  the  refractory 
period persists almost to the end of the active state. Recruitment of increasing 
numbers of active motor units plays a  major role in augmenting  the tension 
developed  by a  skeletal  muscle,  whereas  all  fibers of the  heart,  which  is  a 
functional  syncytium, are normally activated during  each cardiac  systole. 
The  tension  generated  by both cardiac and  skeletal muscle fibers is influ- 
enced  by  initial  fiber  length  (the  length-tension  relationship  of  skeletal 
muscle,  and  Starling's  law  of the  heart),  but  the  relatively  less  compliant 
myocardial fiber appears  to operate with  shorter  sarcomeres  than  does that 
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of skeletal muscle  (1).  The finding that the cardiac ventricle does not nor- 
mally function with extended sarcomeres, a  condition where increasing fiber 
length decreases  active  tension  by  reducing  the  number  of sites  for  inter- 
action between actin and myosin (2), may reflect the geometrical constraints 
upon the performance of the intact heart (3, 4). Because the heart is a hollow 
muscular pump in which impaired contractile performance will increase the 
residual volume at  the end of systole, a  stable equilibrium can be achieved 
only when dilatation improves the ability  to  eject.  Thus,  the heart  cannot 
function chronically on the descending limb of the Starling curve  (5),  while 
it  is  possible  for  a  skeletal  muscle  to  operate  at  lengths  greater  than  rest 
length. 
The  heart's  hemodynamic performance in  the living animal is regulated 
primarily by changes in myocardial contractility,  the potential of the myo- 
cardial fiber  to perform work at  any given rest length. These variations in 
myocardial  contractility  are  paralleled  by  marked  changes  in  shortening 
velocity (6-8),  whereas alterations in skeletal muscle contractility, which are 
much less  prominent and  probably  without physiological significance,  are 
accompanied by little or no change in shortening velocity (9,  10).  Examina- 
tion  of  the  biochemical  characteristics  of  the  cardiac  contractile  proteins 
permits evaluation of some of the mechanisms by which the intensity of the 
heart's contractile process can be modulated. 
INDIVIDUAL  MYOFIBRILLAR  PROTEINS 
Three proteins, actin, myosin, and tropomyosin, comprise most of the myo- 
fibrillar  protein  of both  cardiac  and  skeletal  muscle.  Other  proteins  may 
belong on this list, but in most cases their function and anatomical location 
within the sarcomere remain uncertain. One exception is the recendy discov- 
ered  calcium-sensitizing protein  (11),  which appears  to play a  central  role 
in the regulation by Ca ~  ~ of cardiac and skeletal actomyosin. The nature of 
this protein remains uncertain. It could be a  native form of tropomyosin (11, 
12),  tropomyosin  complexed with  an  additional  protein  (13,  13 a),  or  an 
additional protein unrelated to tropomyosin (14,  15). 
Actin 
Comparison of actins from cardiac and skeletal muscles has revealed no differ- 
ences  in  physiochemical properties  (16),  amino acid  compositions  (17),  or 
the number of sulfhydryl groups (18).  The influences of cations and nucleo- 
tides on sulfhydryl reactivity, which appears to provide a  sensitive index of 
conformational changes in  the G-actin  monomer (19),  are  similar in  both 
cardiac  and  skeletal  actins  (18).  Most  significant  from  the  physiological 
standpoint is  the ability  of actin  to  activate myosin ATPase  activity.  This 
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Tropomyosin 
No differences between the physiochemical properties and amino acid com- 
positions  of cardiac  and  skeletal  tropomyosins  (tropomyosin  B)  have  been 
found, and there is no evidence that the heart contains significant amounts 
of tropomyosin A  (paramyosin)  (22).  Mammalian skeletal tropomyosin has 
a  dual action upon the Mg++-activated reconstituted actomyosin made from 
skeletal muscle (23). At low ionic strengths tropomyosin stimulates the Mg  ++- 
activated ATPase activity and abbreviates  the clearing phase that precedes 
superprecipitation,  whereas at high ionic strengths  this protein inhibits  this 
ATPase activity and delays superprecipitation  (23).  These phenomena have 
not been extensively studied in the case of the cardiac contractile proteins, 
TABLE  I 
COMPARISON  OF  THE  ATPASE  ACTIVITIES  OF  RABBIT 
RED  SKELETAL,  WHITE  SKELETAL,  AND  CARDIAC  MYOSINS 
ATPase Activity 
Cation  White skeletal  Red skeletal  Cardiac 
btmole P¢/min/mg  ~nole Pi/min/mg  IJtnole Pi/min/mg 
2.0 mM Mg  ++  0.00974"0.0007*  0.00234"0.0005  0.00244"0.0004 
1.0 rn~ Ca  ++  0.600-+-0.038  O. 1304-0.005  O. 1064-0.016 
Reactions were carried out at 25°C in 10 rr~ ATP, 0.1 M KC1, and 1.0 mM Tris acetate at pH 6.8. 
From  Katz  et  al.  (21). 
*  Standard  error of the mean. 
but preliminary findings indicate that cardiac  tropomyosin, like its skeletal 
homologue, stimulates actomyosin at low ionic strengths  (Katz, A.  M.  Un- 
published observations). 
Myosin 
The over-all molecular dimensions of cardiac and white skeletal myosins are 
similar (24-26),  as  are  several  solvent-induced  changes  in  secondary  and 
tertiary structure  (27).  On  the other hand, differences have been found  in 
cysteine content (20),  sensitivities to proteolytic enzymes (28,  29),  immuno- 
logical specificity (30,  31),  and the amino acid sequence around one of the 
cysteine residues  (32). 
The lower ATPase activity of rabbit cardiac myosin, compared to that of 
rabbit  skeletal myosin,  was  first  reported  in  1942  by  Bailey  (33),  but  the 
myosins examined in this  pioneering study contained unknown amounts of 
actin, which was then an unrecognized protein.  Subsequent comparisons of 
more highly purified rabbit skeletal myosins with myosins obtained from the 
hearts of larger mammals  (dogs, cattle, sheep)  confirmed the lower ATPase 188  COMPARATIVE  ASPECTS  OF  MUSCULAR  CONTRACTION 
activities of the latter. The possibility that these findings represented a species 
difference, rather than a true difference between cardiac and skeletal myosins, 
was raised by the finding that dog skeletal myosin had only slightly higher 
ATPase activity than dog cardiac myosin (26).  However, a  careful study of 
highly purified rabbit  cardiac  and  skeletal myosins (20)  confirmed Bailey's 
earlier finding. This discrepancy was resolved by the  finding that the ATPase ac- 
tivity of rabbit red skeletal myosin was less than that of white skeletal myosin 
(34,  35),  a  conclusion suggested independently by histochemical studies of 
these  muscle types  in  man (36),  and  by  the  observation  that  dog  skeletal 
muscle is composed principally of red fibers. Examination of myosins purified 
from red  skeletal,  white  skeletal,  and  cardiac  muscle,  all  from  the  rabbit, 
revealed  the  ATPase  activities  of red  skeletal  and  cardiac  myosins  to  be 
similar to each other, but less  than that of white skeletal myosin (Table I). 
TABLE  II 
CALCIUM SENSITIVITIES  OF  THE  INITIAL 
Mg++-ACTIVATED ATPASE ACTIVITY  OF 
RECONSTITUTED  CARDIAC ACTOMYOSINS 
ATPase activity 
Actomyosin  made with  0.1 mu CaCl2  0.25 mu EGTA 
Tropomyosin-free actin 
Actin-tropomyosin complex 
#mote P~/min/mg  ~nole Pg/min/mg 
0.0077  0.0066 
0.0142  0.0081 
Results obtained with 0.5  mg/ml myosin and  either 0.125  mg/ml tropomyosin-free  actin  or 
0.167  mg/ml of the  actin-tropomyosin complex in  1.0  mM MgATP, 0.10  M KC1,  and  20  mM 
histidine, pH 6.8,  at 25°C. The ATPase activity of the myosin alone in the presence of EGTA 
was 0.0039 ttmole Pi/min/mg. 
Comparison of the  dynamic  constants  of red  and  white  skeletal  muscle 
function  suggests  that  myosin  ATPase  activity  may  determine  Vm~x, the 
maximal shortening velocity of the unloaded muscle.  In red skeletal muscle 
Vm~ is approximately 1~ that of white skeletal muscle (37, 38), a ratio similar 
to that seen between the myosin ATPase activities of these two muscle types 
(21,  34).  On  the other hand,  it is unlikely that  the ATPase activity of the 
contractile proteins influences P0, the maximal force-generating ability of the 
muscle,  because  the  tetanic  tensions per  unit of cross-sectional area  of red 
and white skeletal muscle do not differ significantly (38). 
While  precise  quantification of the dynamic constants of cardiac  muscle 
function is difficult  (39),  both  the shortening velocity and  force-generating 
capacity of the myocardium are less than in white skeletal muscle  (8).  The 
large mitochondrial content of heart muscle (40), which significantly reduces 
the  fraction  of cross-sectional  area  occupied by  the myofilaments, appears 
to be partly responsible for the low tension generated by the myocardium. ARNO~  M.  KATZ  Regulation of Cardiac Muscle Contractility  189 
The heart's  slow  contraction,  like  that of red skeletal  muscle,  probably  re- 
fleets,  in  part  at  least,  the  weak  cardiac  myosin ATPase  activity,  but  the 
myocardium,  unlike  red  skeletal  muscle,  appears  to  have  a  variable  Vm~x 
(8). This latter property of cardiac  muscle suggests  that regulation of myo- 
cardial contractility is achieved by variations in the activity of cardiac acto- 
myosin. 
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FIGURE  1.  Influence of Ca  ++  on  the initial Mg++-activated ATPase activities of re- 
constituted actomyosins prepared from rabbit white skeletal myosin (a) and dog cardiac 
myosin  (b).  The  myosin concentrations were  0.50  mg/ml  and  the  concentrations  of 
skeletal (O)  and cardiac (o)  actin-tropomyosin complexes were  0.167  mg/ml.  All ex- 
periments were carried out at 25°12 in 0.08 M KCI, 1.0 m_~ MgATP, and 20 mM histidine 
at pH 6.8. Free Ca  ++ concentration, expressed as pea ( -log [Ca++]), was buffered with 
EGTA and 12aEGTA,  the total EGTA concentration being  1.0 raM. The ATPase ac- 
tivities of the myosins alone are plotted by dashed lines. Figure reprinted by permission of the 
American Heart Association, Inc., from Circulation Research, 1966, 19:1064. 
Calcium-Sensitizing Proteins 
When highly purified skeletal actin and myosin are combined, the resulting 
actomyosin is in a  state analogous to permanent activation  (11,  13)  in that 
removal of calcium by EGTA [1,2-bis(2-dicarboxyethylaminoethoxy)ethane] 
or other calcium-chelating agents inhibits neither superprecipitation (11)  nor 
ATPase activity (13).  Reconstituted  cardiac actomyosin made from highly 
purified cardiac actin and cardiac myosin is similarly insensitive to calcium I9o  COMPARATIVE  ASPECTS  OF  MUSCULAR  CONTRAGTION 
removal (Table II).  Calcium sensitivity can be restored to both cardiac and 
skeletal actomyosin by "native tropomyosin" (41), or by preparing the actin 
under conditions that cause a  tropomyosin-containing protein complex to be 
extracted from the acetone-dried muscle powder along with the actin (Table 
II)  (13,  42,  43).  This protein complex, isolated by virtue of its  binding to 
F-actin, inhibits the activation of myosin by actin at low free Ca  ++ concentra- 
tions  (13).  The  Ca ++  sensitivities conferred  by  the  tropomyosin-containing 
protein complexes extracted from cardiac and white skeletal muscles are the 
same  (42)  (Fig.  1). 
CARDIAC  ACTOMYOSIN 
The mechanisms responsible for the control of myocardial contractility can be 
studied in highly purified cardiac actomyosin systems, which preserve many 
TABLE  III 
COMPARISON  OF  THE  MYOCARDIAL  CALCIUM  UPTAKE  DURING 
A  POSITIVE  RATE  STAIRCASE  AND  THE  CALCIUM  REQUIRED 
TO  PRODUCE  A  SIMILAR  INCREASE  IN  CARDIAC 
ACTOMYOSIN  ATPASE  ACTIVITY 
Myosin content of the heart 
Sensitivity of  actomyosin  ATPase  to  changing 
level of bound calcium 
Estimated change in total myocardial calcium 
needed to effect a  40% increase in actomyosin 
ATPase 
Calcium  uptake  accompanying 40%  contrac- 
tility increase 
50-80 ~moles/kg wet weight 
An increase of 0.3 mole calcium per mole of 
myosin effects a 40% increase in activity 
15-24/~moles/kg wet weight 
20 t~moles/kg wet weight 
features  of the  contractile  apparatus  of the intact heart.  Such actomyosins 
can be made to superprecipitate, an in vitro form of contraction  (44);  they 
hydrolyze ATP,  which appears  to  provide the immediate source of energy 
for muscular contraction (45); and their activity is modified by low concen- 
trations of calcium ion in a manner that appears analogous to the physiologi- 
cal role of this ion in effecting excitation-contraction coupling (42,  43, 46). 
Because  changes  in  myocardial  contractility  are  paralleled  by  changes  in 
Vmax, and because a direct relationship between Vm,x and the ATPase activity 
of the contractile proteins probably exists (47), enhanced cardiac actomyosin 
ATPase  activity in  vitro might be analogous to  the  accelerated  shortening 
velocity that accompanies increased contractility in vivo. Two ionic mecha- 
nisms  that  could  bring  about  such changes in  the  intact  heart  have  been 
identified. 
Variations in the amount of calcium released during excitation-contraction ARNO~  M.  KATZ  Regulation  of Cardiac Muscle Contractility  [9[ 
coupling would be expected to modify myocardial contractility and shorten- 
ing velocity if the heart's contraction is normally limited by the availability of 
intracellular calcium. The latter view is  supported  by  the finding that  the 
cardiac sarcoplasmic reticulum, which is presumed to contain this calcium, is 
less  extensive than  that of skeletal muscle  (48-50).  Because the sensitivities 
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FIoum~ 2.  Stimulation of cardiac actomyosin ATPase activity when Na  + is substituted 
for K +. The initial Mg++-activated ATPase activity of a  Ca++-sensitive reconstituted 
cardiac actomyosin, made with 0.50 mg/ml myosin and 0.167 mg/ml of the actin-tropo- 
myosin complex, was measured at 25°C in 1.0 rr~ MgATP, 0.1 mM CaCI~, and 10 rnM 
histidine buffer at pH 6.8. In each reaction the total concentration of Na  + and K + was 
0.08 M.  Figure reprinted by permission of the American Heart  Association, Inc., from Circulation 
Research, 1966,  19:1066. 
of cardiac  and  skeletal actomyosins to changing levels of Ca  ++  are similar 
(42,  43, 51),  these anatomical findings indicate that the heart's sarcoplasmic 
reticulum may normally contain less calcium than is needed to activate the 
cardiac actomyosin fully. If the degree of activation of the heart's  contractile 
proteins is, in fact, limited by the availability of calcium in the sarcoplasmic 
reticulum,  a  net  gain  in  intracellular  calcium  could  increase  contractile 
force.  Calcium uptake has been noted during a  number of inotropic  inter- 
ventions, for example, during the positive staircase that accompanies an in- 
creased frequency of stimulation  (52-54).  In the dog papillary muscle  per- x92  COMPARATIVE ASPECTS OF  MUSCULAR CONTRACTION 
fused  through  its  arterial  vessels,  a  40%  increase  in  isometric  tension  is 
accompanied by a  net gain of approximately 20 #moles of  calcium per kgwet 
weight, which appears to be in a  homogeneous, kinetically defined compart- 
ment (54). The myosin content of the ventricle is 50-80 #moles/kg wet weight 
(see reference 42 for details of this calculation), and, where  the sensitivity of 
actomyosin to changing Ca  ++ concentration  is maximal  (55),  an increase of 
approximately 0.3 #mole of calcium per mole of myosin would effect a  40°~ 
0.6. 
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FIOUP.E 3.  Stimulation of the  superprecipitation of cardiac  actomyosin when Na  +  is 
substituted for K +. The changes in absorbancy at 560 m/2 of 0.667 mg/ml cardiac acto- 
myosin, containing 0.50  mg/ml  myosin and  0.167  mg/ml of the  actin-tropomyosin 
complex, were measured in 0.080  M KC1 (lower curve) and 0.045  M KCI plus 0.035  M 
NaC1  (upper curve). Reactions were carried out at 25°C in 0.1  irm CaCI2, 0.33  mM 
MgATP, and 20 mM histidine at pH 6.8. Figure reprinted by permission of the American Heart 
Association, Inc., from Circulation Research, 1966, 19:1067. 
increase in ATPase activity (Table III). The relationship between free Ca++ 
concentration and actomyosin-bound calcium has been  carefully defined for 
white skeletal actomyosin; in the case of cardiac actomyosin, a  similar distri- 
bution appears  to exist (51,  55).  The additional calcium needed to increase 
cardiac actomyosin ATPase activity by 40%,  15-24 #moles/kg wet weight, is 
thus the same as  that actually taken up by  the heart during a  comparable 
gain  in  contractility.  Calculations  such  as  these  cannot  establish  that  the 
observed myocardial calcium uptake provides an increased quantum of cal- 
cium to be released during the heart's contraction, thereby enhancing myo- 
cardial contractility. On the other hand, the data now available fit well with 
this postulated relationship. 
A  second  ionic  mechanism by  which  myocardial  contractility  could  be 
regulated has been suggested by the observation that exchange of intracellular A~Notz~ :M.  KATZ  Regulation  of Cardiac Muscle Contractility  I93 
K÷ with extracellular Na  + accompanies a  variety of interventions which in- 
crease myocardial contractility (56-59). The possibility that the cardiac myo- 
fibril is more active in the presence of Na  + than K + is supported by the find- 
ing  that  both ATPase  activity  (Fig.  2)  and  superprecipitation  (Fig.  3)  of 
highly purified cardiac actomyosin are stimulated when K + is replaced by an 
equimolar amount of Na  +  (42).  The relatively small effects of Na+-K  + ex- 
change on actomyosin are seen only when large quantities of Na  + are sub- 
stituted for K +,  however,  so  that the physiological significance of this phe- 
nomenon remains uncertain. 
The different effects of Na  ÷ and K+ on cardiac actomyosin ATPase activity 
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FXOURE 4.  Effects  of alkali metal ions on the initial Mg++-activated  ATPase activity of 
rabbit  white skeletal actomyosin. Reconstituted actomyosin, consisting of 0,5  mg/ml 
myosin and 0.125 mg/ml tropomyosin-free  act.in, was studied in 0.026 ~t KCI, 1.0 mM 
MgATP, 0.I mM CaCI~, and  10 ram histidine, pH 6.8, at 25°C. Each alkali metal ion 
was added as the chloride to give a total (KC1 +  MeC1) of 0.I00 M. The vertical bars 
represent one standard error of  the mean of three determinations. 
do  not  appear  to  be  related  to  the  structure-disrupting  actions  of higher 
concentrations of these cations.  The higher  actomyosin ATPase  activity in 
the presence of Na  + is the converse of the greater inhibition by Na  + than by 
K + of the ATPase activity of myosin alone  (60).  Furthermore, the effects of 
other  alkali metal  ions  on  the Mg++-activated skeletal  actomyosin ATPase 
activity (Fig. 4)  do not parallel their abilities to perturb  the secondary and 
tertiary structures of proteins (61). It is thus more likely that these ions act at a 
specific site on the actomyosin complex, perhaps by competing for Ca  ++ (55). 
During the past 20 years many attempts have been made to demonstrate 
an action of inotropic drugs upon the heart's contractile proteins. The results 
of most of these studies have been negative, but occasional positive results have 
been reported  (see  reference 62  for a  review of some of this literature). We 
have found no effects of either cardiac glycosides (62) or norepinephrine (63) x94  COMPARATIVE  ASPECTS  OF  MUSCULAR  CONTRACTION 
upon the highly purified,  calcium-sensitive,  reconstituted  actomyosin.  While 
these  negative  findings do  not  exclude  such  a  direct  action  of these  drugs, 
they  are  in  accord  with  physiological  evidence  suggesting  that  these  agents 
act  indirectly  upon  the  contractile  proteins.  Most  significant  is  the  finding 
that, after maximal contractility is achieved  by any of a  number of agents or 
ionic  manipulations,  additional  inotropic  interventions  of  a  different  class 
bring about no further enhancement of myocardial  contractility  (64). 
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Discussion 
Dr.  Sandow: I  think,  Dr.  Katz,  that  you have short-changed  skeletal muscle  in 
stating  that it has little capacity for having its contractility altered.  It depends on 
what you do with it. For example, the zinc ion, which has a depressive effect on heart 
muscle,  can  greatly prolong the  active  state  of skeletal muscle  and  so cause  it  to 
produce a much bigger twitch output. 
Now,  this  difference between heart  and  skeletal muscle raises  some questions  as 
to mechanism. The available evidence indicates that this is fundamentally a problem 
involving difference in membrane function, which, though very interesting, will not 
be discussed further since our interest here is essentially in the contractile process. 
Dr.  Katz:  I  certainly agree.  I  am aware of these findings,  but I  didn't mention 
them because they are probably of little physiological importance. My main  point is 
that  changes  in  cardiac muscle  contractility, unlike  those which occur  in  skeletal 
muscle,  are  paralleled  by changes in  Vm~,. This strongly suggests that  these  func- 
tionally important variations in myocardial contractility are  due  to changes  in  the 
extent of activation of the heart's contractile proteins. 